Generation of Dipeptidyl Peptidase-IV-Inhibiting Peptides from β -Lactoglobulin Secreted by Lactococcus lactis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Shigemori, Suguru ^a,b   Oshiro, Kazushi ^a   Wang, Pengfei ^a   Yamamoto, Yoshinari ^a   Wang, Yeqin ^a   Sato, Takashi ^c   Uyeno, Yutaka ^a   Shimosato, Takeshi ^a  

^a SHINSHU UNIVERSITY   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; BACTERIAL VACCINE; DIPEPTIDYL PEPTIDASE IV INHIBITOR; FREUND ADJUVANT; LANTIBIOTIC; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; NISIN; RECOMBINANT BETA LACTOGLOBULIN; TRYPSIN; UNCLASSIFIED DRUG; DIPEPTIDYL PEPTIDASE IV; LACTOGLOBULIN; PEPTIDE;

ALLERGENICITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG PURIFICATION; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION SYSTEM; IMMUNOREACTIVITY; LACTOCOCCUS LACTIS; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PROTEIN DEGRADATION; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; GENE VECTOR; ISOLATION AND PURIFICATION; METABOLISM;

LACTOCOCCUS LACTIS;

ANIMALS; DIPEPTIDYL PEPTIDASE 4; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FEMALE; GENETIC VECTORS; LACTOCOCCUS LACTIS; LACTOGLOBULINS; MICE, INBRED BALB C; NISIN; PEPTIDES; TRYPSIN;

EID: 84930179307     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/393598     Document Type: Article

References (34)

1. B. Hernandez-Ledesma, I. Recio, and L. Amigo, " β-Lactoglobulin as source of bioactive peptides, " Amino Acids, vol. 35, no. 2, pp. 257-265, 2008.
2. D. E. W. Chatterton, G. Smithers, P. Roupas, and A. Brodkorb, "Bioactivity of β-lactoglobulin and α-lactalbumin-technological implications for processing, " International Dairy Journal, vol. 16, no. 11, pp. 1229-1240, 2006.
3. I. M. E. Lacroix and E. C. Y. Li-Chan, "Inhibition of dipeptidyl peptidase (DPP)-IV and α-glucosidase activities by pepsintreated whey proteins, " Journal of Agricultural and Food Chemistry, vol. 61, no. 31, pp. 7500-7506, 2013.
4. I. M. Lacroix and E. C. Li-Chan, "Isolation and characterization of peptides with dipeptidyl peptidase-IV inhibitory activity frompepsin-treated bovinewhey proteins, " Peptides, vol. 54, pp. 39-48, 2014.
5. A. B. Nongonierma and R. J. Fitzgerald, "Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk proteinderived dipeptides and hydrolysates, " Peptides, vol. 39, no. 1, pp. 157-163, 2013.
6. S. T. Silveira, D. Martinez-Maqueda, I. Recio, and B. Hernandez-Ledesma, "Dipeptidyl peptidase-IV inhibitory peptides generated by tryptic hydrolysis of a whey protein concentrate rich in β-lactoglobulin, " Food Chemistry, vol. 141, no. 2, pp. 1072-1077, 2013.
7. G. Tulipano, V. Sibilia, A. M. Caroli, and D. Cocchi, "Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors, " Peptides, vol. 32, no. 4, pp. 835-838, 2011.
8. M. Uchida, Y. Ohshiba, and O. Mogami, "Novel dipeptidyl peptidase-4-inhibiting peptide derived from β-lactoglobulin, " Journal of Pharmacological Sciences, vol. 117, no. 1, pp. 63-66, 2011.
9. R. Thoma, B. Loffler, M. Stihle, W. Huber, A. Ruf, and M. Hennig, "Structural basis of proline-specific exopeptidase activity as observed in human dipeptidyl peptidase-IV, " Structure, vol. 11, no. 8, pp. 947-959, 2003.
10. G. E. Limand P. L. Brubaker, "Glucagon-like peptide 1 secretion by the L-cell: the view from within, " Diabetes, vol. 55, no. 2, pp. S70-S77, 2006.
11. L. K. Phillips and J. B. Prins, "Update on incretin hormones, " Annals of the New York Academy of Sciences, vol. 1243, pp. E55-E74, 2011.
12. C. Daniel, Y. Roussel, M. Kleerebezem, and B. Pot, "Recombinant lactic acid bacteria as mucosal biotherapeutic agents, " Trends in Biotechnology, vol. 29, no. 10, pp. 499-508, 2011.
13. S. Shigemori, S. Yonekura, T. Sato, M. Nakanishi, H. Otani, and T. Shimosato, "Expression of a biologically active GFP-αS1-casein fusion protein in Lactococcus lactis, " Current Microbiology, vol. 64, no. 6, pp. 569-575, 2012.
14. S. Shigemori, S. Yonekura, T. Sato, H. Otani, and T. Shimosato, "Expression of the immunoreactive buckwheat major allergenic storage protein in Lactococcus lactis, " Applied Microbiology and Biotechnology, vol. 97, no. 8, pp. 3603-3611, 2013.
15. Y. Ito, S. Shigemori, T. Sato et al., "Class I/II hybrid inhibitory oligodeoxynucleotide exerts Th1 and Th2 double immunosuppression, " FEBS Open Bio, vol. 3, pp. 41-45, 2013.
16. T. Shimosato, M. Tohno, T. Sato et al., "Identification of a potent immunostimulatory oligodeoxynucleotide from Streptococcus thermophilus lacZ, " Animal Science Journal, vol. 80, no. 5, pp. 597-604, 2009.
17. J. M. Wells and A. Mercenier, "Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria, " Nature Reviews Microbiology, vol. 6, no. 5, pp. 349-362, 2008.
18. E. Morello, L. G. Bermudez-Humaran, D. Llull et al., "Lactococcus lactis, an efficient cell factory for recombinant protein production and secretion, " Journal of Molecular Microbiology and Biotechnology, vol. 14, no. 1-3, pp. 48-58, 2007.
19. M. Bahey-El-Din, C. G. M. Gahan, and B. T. Griffin, "Lactococcus lactis as a cell factory for delivery of therapeutic proteins, " Current GeneTherapy, vol. 10, no. 1, pp. 34-45, 2010.
20. D. S. Pontes, M. S. P. de Azevedo, J. M. Chatel, P. Langella, V. Azevedo, and A. Miyoshi, "Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems, " Protein Expression and Purification, vol. 79, no. 2, pp. 165-175, 2011.
21. P. G. de Ruyter, O. P. Kuipers, and W. M. de Vos, "Controlled gene expression systems for Lactococcus lactis with the foodgrade inducer nisin, " Applied and Environmental Microbiology, vol. 62, no. 10, pp. 3662-3667, 1996.
22. I. Mierau andM. Kleerebezem, "10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis, " Applied Microbiology and Biotechnology, vol. 68, no. 6, pp. 705-717, 2005.
23. X. X. Zhou, W. F. Li, G. X. Ma, and Y. J. Pan, "The nisincontrolled gene expression system: construction, application and improvements, " Biotechnology Advances, vol. 24, no. 3, pp. 285-295, 2006.
24. L. G. Bermudez-Humaran, P. Kharrat, J. Chatel, and P. Langella, "Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines, " Microbial Cell Factories, vol. 10, supplement 1, article S4, 2011.
25. E. Gross and J. L. Morell, "The structure of nisin, " Journal of the American Chemical Society, vol. 93, no. 18, pp. 4634-4635, 1971.
26. M. R. Islam, J. Nagao, T. Zendo, and K. Sonomoto, "Antimicrobial mechanism of lantibiotics, " Biochemical Society Transactions, vol. 40, no. 6, pp. 1528-1533, 2012.
27. Y. Charng, C. Lin, and C. Hsu, "Inhibition of allergeninduced airway inflammation and hyperreactivity by recombinant lactic-acid bacteria, " Vaccine, vol. 24, no. 33-34, pp. 5931-5936, 2006.
28. A. Kruisselbrink, M. H. Den Bak-Glashouwer, C. E. G. Havenith, J. E. R. Thole, and R. Janssen, "Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses, " Clinical and Experimental Immunology, vol. 126, no. 1, pp. 2-8, 2001.
29. P. Rigaux, C. Daniel, M. Hisbergues et al., "Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy, " Allergy, vol. 64, no. 3, pp. 406-414, 2009.
30. I. L. Huibregtse, V. Snoeck, A. de Creus et al., "Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin, "Gastroenterology, vol. 133, no. 2, pp. 517-528, 2007.
31. C. Daniel, A. Repa, C. Wild et al., "Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1, " Allergy, vol. 61, no. 7, pp. 812-819, 2006.
32. K. Ohkouchi, S. Kawamoto, K. Tatsugawa et al., "Prophylactic effect of Lactobacillus oral vaccine expressing a Japanese cedar pollen allergen, " Journal of Bioscience and Bioengineering, vol. 113, no. 4, pp. 536-541, 2012.
33. M. S. P. de Azevedo, S. Innocentin, F. A. Dorella et al., "Immunotherapy of allergic diseases using probiotics or recombinant probiotics, " Journal of Applied Microbiology, vol. 115, no. 2, pp. 319-333, 2013.
34. K. Adel-Patient, S. Ah-Leung, C. Creminon et al., "Oral administration of recombinant Lactococcus lactis expressing bovine β-lactoglobulin partially prevents mice from sensitization, " Clinical and Experimental Allergy, vol. 35, no. 4, pp. 539-546, 2005.